NASDAQ:SSKN Strata Skin Sciences (SSKN) Stock Price, News & Analysis $1.89 -0.02 (-1.26%) As of 08/7/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Strata Skin Sciences Stock (NASDAQ:SSKN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Strata Skin Sciences alerts:Sign Up Key Stats Today's Range$1.88▼$1.9550-Day Range$1.89▼$2.5852-Week Range$1.86▼$3.79Volume5,532 shsAverage Volume45,210 shsMarket Capitalization$7.88 millionP/E RatioN/ADividend YieldN/APrice Target$6.00Consensus RatingBuy Company Overview STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. Read More Strata Skin Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks45th Percentile Overall ScoreSSKN MarketRank™: Strata Skin Sciences scored higher than 45% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingStrata Skin Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageStrata Skin Sciences has received no research coverage in the past 90 days.Read more about Strata Skin Sciences' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Strata Skin Sciences are expected to grow in the coming year, from ($1.05) to ($1.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Strata Skin Sciences is -0.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Strata Skin Sciences is -0.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioStrata Skin Sciences has a P/B Ratio of 1.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Strata Skin Sciences' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.26% of the float of Strata Skin Sciences has been sold short.Short Interest Ratio / Days to CoverStrata Skin Sciences has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Strata Skin Sciences has recently increased by 78.38%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldStrata Skin Sciences does not currently pay a dividend.Dividend GrowthStrata Skin Sciences does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.26% of the float of Strata Skin Sciences has been sold short.Short Interest Ratio / Days to CoverStrata Skin Sciences has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Strata Skin Sciences has recently increased by 78.38%, indicating that investor sentiment is decreasing significantly. News and Social Media1.0 / 5News Sentiment-0.25 News SentimentStrata Skin Sciences has a news sentiment score of -0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Strata Skin Sciences this week, compared to 1 article on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Strata Skin Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders39.00% of the stock of Strata Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 32.43% of the stock of Strata Skin Sciences is held by institutions.Read more about Strata Skin Sciences' insider trading history. Receive SSKN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Strata Skin Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address SSKN Stock News HeadlinesSTRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ PatientsAugust 7 at 8:15 AM | globenewswire.comSTRATA Skin Sciences to Announce Q2 2025 Results on August 13August 2, 2025 | msn.comBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. August 8 at 2:00 AM | Crypto 101 Media (Ad)STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate UpdateJuly 31, 2025 | globenewswire.comSTRATA Skin Sciences, Inc. (SSKN) - Yahoo FinanceJuly 18, 2025 | finance.yahoo.comStrata Skin Sciences (NASDAQ:SSKN) Stock, Short Interest ReportJuly 9, 2025 | benzinga.comStrata Skin Sciences Earnings Estimates, EPS & Revenue | NASDAQ:SSKN | BenzingaJuly 9, 2025 | benzinga.comSSKN STRATA Skin Sciences, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comSee More Headlines SSKN Stock Analysis - Frequently Asked Questions How have SSKN shares performed this year? Strata Skin Sciences' stock was trading at $2.91 at the beginning of 2025. Since then, SSKN stock has decreased by 35.1% and is now trading at $1.8890. How were Strata Skin Sciences' earnings last quarter? Strata Skin Sciences, Inc. (NASDAQ:SSKN) issued its quarterly earnings data on Wednesday, May, 14th. The medical device company reported ($0.58) EPS for the quarter, missing analysts' consensus estimates of ($0.56) by $0.02. The medical device company earned $6.81 million during the quarter, compared to the consensus estimate of $7.28 million. Strata Skin Sciences had a negative trailing twelve-month return on equity of 138.22% and a negative net margin of 27.22%. Read the conference call transcript. When did Strata Skin Sciences' stock split? Shares of Strata Skin Sciences reverse split before market open on Friday, June 7th 2024.The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Strata Skin Sciences? Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Strata Skin Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Strata Skin Sciences investors own include Amarin (AMRN), AbbVie (ABBV), OPKO Health (OPK), AT&T (T), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD) and Avino Silver & Gold Mines (ASM). Company Calendar Last Earnings5/14/2025Today8/07/2025Next Earnings (Estimated)8/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMedical Equipment Current SymbolNASDAQ:SSKN CIK1051514 Webwww.strataskinsciences.com Phone(215) 619-3200Fax215-619-3208Employees120Year FoundedN/APrice Target and Rating Average Price Target for Strata Skin Sciences$6.00 High Price Target$6.00 Low Price Target$6.00 Potential Upside/Downside+217.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($2.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.09 million Net Margins-27.22% Pretax Margin-27.72% Return on Equity-138.22% Return on Assets-24.37% Debt Debt-to-Equity Ratio5.71 Current Ratio1.05 Quick Ratio0.87 Sales & Book Value Annual Sales$33.56 million Price / Sales0.23 Cash FlowN/A Price / Cash FlowN/A Book Value$1.19 per share Price / Book1.59Miscellaneous Outstanding Shares4,170,000Free Float2,544,000Market Cap$7.88 million OptionableNot Optionable Beta0.66 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:SSKN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Strata Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Strata Skin Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.